DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
MARVELON
3
Small molecule
Investigational
Unknown
Unknown
Premenstrual Syndrome
Unknown
MARVELON
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H54O3
Molecular Weight:
606.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INDIGO
3
Small molecule
Investigational
Unknown
Unknown
Anus Neoplasms; Dermatitis, Atopic; Psoriasis; Leukemia, Promyelocytic, Acute
Unknown
INDIGO
×
Maximum Phase:
3
First Approval:
None
UNII:
1G5BK41P4F
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O2
Molecular Weight:
262.27
AlogP:
2.81
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
0.0
Source:
LASOFOXIFENE
3
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Osteoporosis
Estrogen receptor modulator
LASOFOXIFENE
×
Maximum Phase:
3
First Approval:
None
UNII:
337G83N988
Molecule Type:
Small molecule
Molecular Formula:
C28H31NO2
Molecular Weight:
413.56
AlogP:
5.73
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ESUBERAPROST
3
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Prostanoid IP receptor agonist
ESUBERAPROST
×
Maximum Phase:
3
First Approval:
None
UNII:
1JSN1I7582
Molecule Type:
Small molecule
Molecular Formula:
C24H30O5
Molecular Weight:
398.5
AlogP:
3.29
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DUTOGLIPTIN
3
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Dipeptidyl peptidase IV inhibitor
DUTOGLIPTIN
×
Maximum Phase:
3
First Approval:
None
UNII:
38EAO245ZX
Molecule Type:
Small molecule
Molecular Formula:
C10H20BN3O3
Molecular Weight:
241.1
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CITICOLINE SODIUM
3
Small molecule
Investigational
Unknown
Unknown
Brain Injuries; Schizophrenia; Substance-Related Disorders; Amphetamine-Related Disorders
Unknown
CITICOLINE SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
7XQ5AKD9YD
Molecule Type:
Small molecule
Molecular Formula:
C14H25N4NaO11P2
Molecular Weight:
510.31
AlogP:
-2.23
PSA:
215.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
SENNA
3
Small molecule
Investigational
Unknown
Unknown
Gastroparesis; Constipation
Unknown
SENNA
×
Maximum Phase:
3
First Approval:
None
UNII:
AK7JF626KX
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBETAPENTANE CITRATE
4
Small molecule
Approved
Unknown
Unknown
Sinusitis
Sigma opioid receptor agonist
CARBETAPENTANE CITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
4SH0MFJ5HJ
Molecule Type:
Small molecule
Molecular Formula:
C26H39NO10
Molecular Weight:
525.6
AlogP:
3.4
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
10.0
Source:
XANTHINOL NIACINATE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
XANTHINOL NIACINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
8G60H12X2D
Molecule Type:
Small molecule
Molecular Formula:
C19H26N6O6
Molecular Weight:
434.45
AlogP:
-2.28
PSA:
105.52
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VONOPRAZAN
4
Small molecule
Approved
Unknown
Unknown
Gastroesophageal Reflux; Helicobacter Infections; Peptic Ulcer
Unknown
VONOPRAZAN
×
Maximum Phase:
4
First Approval:
None
UNII:
1R5L3J156G
Molecule Type:
Small molecule
Molecular Formula:
C17H16FN3O2S
Molecular Weight:
345.4
AlogP:
2.65
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BAMETHAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BAMETHAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Y08ZFJ9TFK
Molecule Type:
Small molecule
Molecular Formula:
C12H19NO2
Molecular Weight:
209.29
AlogP:
1.82
PSA:
52.49
HBD:
3.0
HBA:
#RotB:
6.0
Source:
NITREFAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Alcohol dehydrogenase inhibitor
NITREFAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
VFD629099M
Molecule Type:
Small molecule
Molecular Formula:
C10H8N4O4
Molecular Weight:
248.2
AlogP:
2.0
PSA:
104.1
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TRISENOX
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TRISENOX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFPIROME SULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CEFPIROME SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
BA5ALU2ZT9
Molecule Type:
Small molecule
Molecular Formula:
C22H24N6O9S3
Molecular Weight:
612.67
AlogP:
-1.04
PSA:
153.92
HBD:
2.0
HBA:
#RotB:
7.0
Source:
HYDROXOCOBALAMIN
4
Small molecule
Approved
OTHER
INJECTION
Colitis, Ulcerative; Shock, Septic; Acne Vulgaris; Anemia
Unknown
HYDROXOCOBALAMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Q40X8H422O
Molecule Type:
Small molecule
Molecular Formula:
C62H89CoN13O15P
Molecular Weight:
1346.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MITIGLINIDE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Unknown
MITIGLINIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
D86I0XLB13
Molecule Type:
Small molecule
Molecular Formula:
C19H25NO3
Molecular Weight:
315.41
AlogP:
2.97
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IODIPAMIDE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODIPAMIDE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
X064O0Y1A4
Molecule Type:
Small molecule
Molecular Formula:
C34H48I6N4O16
Molecular Weight:
1530.19
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FORXIGA
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FORXIGA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EXIFONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
EXIFONE
×
Maximum Phase:
4
First Approval:
None
UNII:
38K9TOD4EG
Molecule Type:
Small molecule
Molecular Formula:
C13H10O7
Molecular Weight:
278.22
AlogP:
1.15
PSA:
138.45
HBD:
6.0
HBA:
#RotB:
2.0
Source:
INDOBUFEN
4
Small molecule
Approved
Unknown
Unknown
Atrial Fibrillation; Thrombosis
Unknown
INDOBUFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
6T9949G4LZ
Molecule Type:
Small molecule
Molecular Formula:
C18H17NO3
Molecular Weight:
295.34
AlogP:
3.43
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ACEFYLLINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACEFYLLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
M494UE2YEP
Molecule Type:
Small molecule
Molecular Formula:
C9H10N4O4
Molecular Weight:
238.2
AlogP:
-1.48
PSA:
99.12
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SULFIRAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SULFIRAM
×
Maximum Phase:
4
First Approval:
None
UNII:
1XHL4Q8P7Y
Molecule Type:
Small molecule
Molecular Formula:
C10H20N2S3
Molecular Weight:
264.49
AlogP:
2.97
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NICORANDIL
4
Small molecule
Approved
Unknown
Unknown
Dementia; Premature Birth; Radiation Pneumonitis; Myocardial Infarction; Severe Acute Respiratory Syndrome; Cardiovascular Diseases
Unknown
NICORANDIL
×
Maximum Phase:
4
First Approval:
None
UNII:
260456HAM0
Molecule Type:
Small molecule
Molecular Formula:
C8H9N3O4
Molecular Weight:
211.18
AlogP:
0.02
PSA:
94.36
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DEBRISOQUIN
4
Small molecule
Unknown
Unknown
Unknown
Hypertension
Norepinephrine transporter inhibitor
DEBRISOQUIN
×
Maximum Phase:
4
First Approval:
None
UNII:
X31CDK040E
Molecule Type:
Small molecule
Molecular Formula:
C10H13N3
Molecular Weight:
175.24
AlogP:
0.94
PSA:
53.11
HBD:
2.0
HBA:
#RotB:
0.0
Source:
FUSIDATE SODIUM
4
Small molecule
Approved
Unknown
Unknown
Infections
Elongation factor G inhibitor
FUSIDATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
J7P3696BCQ
Molecule Type:
Small molecule
Molecular Formula:
C31H47NaO6
Molecular Weight:
538.7
AlogP:
5.67
PSA:
104.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
NIALAMIDE
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Monoamine oxidase inhibitor
NIALAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
T2Q0RYM725
Molecule Type:
Small molecule
Molecular Formula:
C16H18N4O2
Molecular Weight:
298.35
AlogP:
1.02
PSA:
83.12
HBD:
3.0
HBA:
#RotB:
7.0
Source:
CYSTINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYSTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
48TCX9A1VT
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2O4S2
Molecular Weight:
240.31
AlogP:
-0.81
PSA:
126.64
HBD:
4.0
HBA:
#RotB:
7.0
Source:
URETHANE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
URETHANE
×
Maximum Phase:
4
First Approval:
None
UNII:
3IN71E75Z5
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
0.1
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
1.0
Source:
POLDINE METHYLSULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
POLDINE METHYLSULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
564C0W9848
Molecule Type:
Small molecule
Molecular Formula:
C22H29NO7S
Molecular Weight:
451.54
AlogP:
2.7
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DIETHYLTOLUAMIDE
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
DIETHYLTOLUAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
FB0C1XZV4Y
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO
Molecular Weight:
191.27
AlogP:
2.48
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
3.0
Source:
GRISEOFULVIN, ULTRAMICROSIZE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
GRISEOFULVIN, ULTRAMICROSIZE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COD LIVER OIL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Supplement
COD LIVER OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
BBL281NWFG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALMITRINE
4
Small molecule
Approved
Unknown
Unknown
Respiratory Insufficiency; Severe Acute Respiratory Syndrome; Respiratory Tract Diseases
Unknown
ALMITRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
9A1222NBG4
Molecule Type:
Small molecule
Molecular Formula:
C26H29F2N7
Molecular Weight:
477.56
AlogP:
4.26
PSA:
69.21
HBD:
2.0
HBA:
#RotB:
10.0
Source:
FLOXACILLIN
4
Small molecule
Approved
Unknown
Unknown
Infections; Renal Insufficiency, Chronic; Osteomyelitis; Skin Diseases; Staphylococcal Infections; Bacterial Infections
Bacterial penicillin-binding protein inhibitor
FLOXACILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
43B2M34G2V
Molecule Type:
Small molecule
Molecular Formula:
C19H17ClFN3O5S
Molecular Weight:
453.88
AlogP:
2.69
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PROGLUMIDE
4
Small molecule
Approved
Unknown
Unknown
Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Gastroesophageal Reflux; Peptic Ulcer
Cholecystokinin receptor antagonist
PROGLUMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
EPL8W5565D
Molecule Type:
Small molecule
Molecular Formula:
C18H26N2O4
Molecular Weight:
334.42
AlogP:
2.3
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
10.0
Source:
1
2
…
160
161
162
163
164
165
166
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA